Chembio Diagnostics
Recent developments from Chembio Diagnostics summarized
Published in Law and Health Weekly, January 20th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Chembio Diagnostics.
Report 1: Chembio Diagnostics, Inc. (CEMI) has reported its financial results for the third quarter ended September 30, 2006.
Revenues for the third quarter of 2006 were $1.02 million, an 8% increase over third quarter 2005 revenues of $945,000. The third quarter 2006 net loss attributable to common stockholders was $2.33 million, or $0.21 per share, compared with a net loss attributable to common stockholders of $1.04 million, or $0.13 per share, for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Awards
Neuropharma receives Frost & Sullivan International Excellence in Technology award - Behavior
Research from Creighton University, Department of Psychology provides new data on behavior - Business & Finance
Genmab discloses details of the issue of shares to GlaxoSmithKline - Business Update
Advancis closes private placement of common equity, files application for Pulsys - Business Update
Analytical Spectral Devices launches portable drug anti-counterfeiting technology - Business Update
Anchen announces approval of generic version of Wellbutrin XL - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
